Cancer imposes catastrophic health expenditure in India, with medicines constituting over 60% of out-of-pocket expenditure. Research shows wide price variations, limited cost containment.
Study published in Nature Cell Biology is fundamental in understanding the ways in which cancer cells can develop drug resistance, one of the main causes of relapse.
Osaka University professor Shimon Sakaguchi, Princeton PhD student Mary E. Brunkow, and US-based Parker Institute for Cancer Immunotherapy director Fred Ramsdell win the Nobel Prize in medicine.
Analysis by network of thousands of researchers and academics from around the world relied on cancer incidence & mortality rates for 204 countries and territories for 47 cancer types.
Cancer care in India is moving beyond AIIMS or Tata Memorial. Doctors are shifting to their hometowns to open hospitals, and district centres are starting to offer chemo and diagnostics.
Study by International Institute for Population Sciences & Tata Memorial Centre, out in Journal of Cancer Policy, based on assessment of cancer patients at Mumbai's Tata Memorial Centre.
Experts say even manufacturers don’t claim e-cigarettes are cessation devices, and no amount of ‘harm reduction’ rhetoric can obscure evidence that these devices inflict serious damage.
Hepatitis D or HDV, which only affects individuals infected with hepatitis B, is associated with a two- to six-fold higher risk of liver cancer compared to hepatitis B alone.
Experts say findings, presented at the ongoing American Society of Clinical Oncology (ASCO) annual meeting in Chicago, have potential to transform how cancer is managed across countries.
In tactical terms, the shirtless protest was worse than a self-goal. Suddenly, the fiascos of the AI Summit were forgotten, and the Youth Congress’s disruption became the issue.
IAF is fine with accepting the aircraft with 'must-haves', even if some other steps remain pending, which may take at least another year, it is learnt.
COMMENTS